HAYA Therapeutics (Series A)
Funding Details
- Date Award
- May 16, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Founding Year
- 2017
- Company Description
- HAYA Therapeutics is focused on advancing RNA-guided therapies for chronic and age-related diseases, particularly through its clinical trials of HTX-001 for heart failure and expanding its RNA-guided genome pipeline.
- Market
- Healthcare
- Location
- Epalinges, Switzerland
- Coinvestors
- Sofinnova Partners, Earlybird Venture Capital